Scenario name,Rate of gonorrhea cases,"% cases successfully treated with CIP, TET, or CRO",% cases susceptible to CIP,% cases susceptible to TET,% cases susceptible to CRO,"Effective lifespan of CIP, TET, and CRO",Effective lifespan of CIP,Effective lifespan of TET,Effective lifespan of CRO,delta - Rate of gonorrhea cases,"delta - Effective lifespan of CIP, TET, and CRO",delta - Effective lifespan of CIP,delta - Effective lifespan of TET,delta - Effective lifespan of CRO
Status quo (no rapid test),"6,927 (4,846, 8,801)","35.0% (24.2%, 45.2%)","72.8% (55.6%, 88.5%)","18.5% (12.1%, 28.0%)","94.3% (90.3%, 96.0%)","12.3 (8.5, 15.8)","25.5 (19.5, 31.0)","6.5 (4.2, 9.8)","33.0 (31.6, 33.6)",,,,,
"(p=None, None), q=(None, None), c=0.500)","7,188 (5,110, 9,234)","42.9% (28.3%, 57.9%)","67.7% (49.1%, 84.1%)","16.6% (10.5%, 25.5%)","95.2% (92.0%, 97.0%)","15.0 (9.9, 20.3)","23.7 (17.2, 29.4)","5.8 (3.7, 8.9)","33.3 (32.2, 34.0)","3.9% (0.9%, 9.3%)","22.7% (4.2%, 49.9%)","-7.2% (-12.5%, -3.0%)","-10.8% (-18.9%, -3.9%)","1.0% (-1.8%, 4.2%)"
"(p=None, None), q=(None, None), c=0.750)","7,356 (5,219, 9,500)","43.9% (28.3%, 60.8%)","66.1% (45.6%, 83.0%)","15.9% (10.1%, 24.2%)","95.2% (91.2%, 97.1%)","15.4 (9.9, 21.3)","23.1 (16.0, 29.0)","5.6 (3.5, 8.5)","33.3 (31.9, 34.0)","6.4% (2.0%, 12.2%)","25.6% (4.2%, 57.1%)","-9.5% (-17.6%, -5.1%)","-14.7% (-24.9%, -7.9%)","1.0% (-2.2%, 5.0%)"
"(p=None, None), q=(None, None), c=1.000)","7,537 (5,359, 9,750)","44.2% (28.3%, 59.7%)","64.7% (44.0%, 82.3%)","15.2% (9.6%, 23.4%)","95.0% (91.0%, 96.9%)","15.5 (9.9, 20.9)","22.6 (15.4, 28.8)","5.3 (3.4, 8.2)","33.3 (31.8, 33.9)","9.0% (2.9%, 17.6%)","26.8% (7.0%, 52.1%)","-11.5% (-21.2%, -5.9%)","-18.5% (-29.1%, -8.9%)","0.8% (-1.9%, 4.4%)"
